Zobrazeno 1 - 10 of 678 pro vyhledávání: '"K. Kragballe"'
2
The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin
Autor: Jeanette Henningsen, Claus Johansen, Lars Iversen, Karsten Kristiansen, K. Kragballe, Majken Westergaard
Publikováno v: Aarhus University
Johansen, C, Kragballe, K, Westergaard, M, Henningsen, J, Kristiansen, K & Iversen, L 2005, ' The mitogen-activated protein kinases p38 and ERK 1/2 are increased in lesional psoriatic skin ', Br. J. Dermatol., vol. 152, no. 1, pp. 37-42 .
Summary Background Alterations in specific signal transduction pathways may explain the hyperproliferation and abnormal differentiation of the keratinocytes as well as the increased expression of inflammatory cytokines seen in psoriasis. Major signal
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e62cf11d83d0e9a76024d00905ce829
https://doi.org/10.1111/j.1365-2133.2004.06304.x
Zobrazit plný text záznamu
3
Contents Vol. 213, 2006
Autor: Alessandra Comessatti, Henedina Antunes, Maria Hedberg, Atsuko Kitagawa, J. Toole, Etsuko Tadaka, Lennart Emtestam, Akiko Yagami, K. Hoffmann, Giuliana Crisman, Hiromi Sanada, T. Simonart, Gojiro Nakagami, Andrew Yule Finlay, J. Stokkermans-Dubois, Mark Anliker, Teoman Zafer Apan, M.M. Delaunay, Iris Zalaudek, Å. Svensson, A. Bibby, Dolores Wolfram, Maria Teresa Fierro, Gerardo Ferrara, Dagmar Simon, G. Wozel, Florence Dalgard, Takeo Maekawa, Nicole Gilgen Bobalj, Christoph A. Meier, Brunello Wüthrich, Sébastien Thalmann, H. Heikkilä, Lasse R. Braathen, M. Monika Weber, Andreas Blum, Simona Osella Abate, Shin Koie, A. Taieb, Ayşen Karaduman, Alice Wiesner, Marcus Schmitt-Egenolf, Sedat Kaygusuz, Peter Schmid-Grendelmeier, J. Peyri Rey, M. de la Brassinne, Pietro Quaglino, J. Austad, F.G. Bechara, Michela Ortoncelli, C. Fleming, K. Kragballe, Yoshizo Asano, Teresa M. Pereira, Hildegunde Piza-Katzer, Shah Jalal, Martin H. Schöni, M. Sand, Alexandar Tzankov, Kayoko Matsunaga, José Carlos Fernandes, Dirk Schneider, Takashi Nagase, Mauro Novelli, Francesco Cusano, Ana Paula Vieira, Jan Lapins, Nark-Kyoung Rho, F. Cambazard, Karin Sartorius, Giovanni Sarracco, Tetsuo Shiohara, Gonca Boztepe, Jann Lübbe, Z. Williams, S. Tas, Renata Ponti, A. Sousa Basto, Giuseppe Argenziano, Chizuko Konya, Maria Grazia Bernengo, B. Vergier, Emmanuel Laffitte, Tetsushi Yoshikawa, T. Jouary, L. Barnes, Gulsen Akoglu
Publikováno v: Dermatology. 213:365-367
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7be18d1a8148d3dae84109df93145c2f
https://doi.org/10.1159/000097638
Zobrazit plný text záznamu
4
An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals
Autor: U, Mrowietz, K, Kragballe, K, Reich, C E M, Griffiths, Y, Gu, Y, Wang, S J, Rozzo
Publikováno v: The British journal of dermatology. 168(2)
The European Consensus Programme (ECP) established pan-European consensus definitions of psoriasis disease severity and treatment goals among 19 psoriasis experts from European nations.To use the ECP treatment goals to retrospectively assess adalimum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b9bdf15df70acf066d601ef3d37916ca
https://pubmed.ncbi.nlm.nih.gov/22880843
Zobrazit plný text záznamu
5
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council
Autor: P C M, van de Kerkhof, K, Kragballe, S, Segaert, M, Lebwohl
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 25(10)
Corticosteroids are the mainstay of topical therapies for the treatment of mild to moderate psoriasis. Selection of vehicle, concentrations of corticosteroid and coadministered medications, and frequency of administration are critical factors that en
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b87656ef6caed992db3d84a3c5ec09a4
https://pubmed.ncbi.nlm.nih.gov/21564329
Zobrazit plný text záznamu
6
Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting
Autor: U, Mrowietz, K, Kragballe, A, Nast, K, Reich
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV. 25
Targeted treatment, early intervention and the use of treatment goals is a new approach in medicine that has been implemented across several disciplines (e.g. diabetes, pulmonary arterial hypertension and rheumatoid arthritis) over the last 5-10 year
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a8494c615daf214a3069c4f4f6179c53
https://pubmed.ncbi.nlm.nih.gov/21470314
Zobrazit plný text záznamu
7
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
Autor: R, Gniadecki, K, Kragballe, T N, Dam, L, Skov
Publikováno v: The British journal of dermatology. 164(5)
Adherence to treatment is an indicator of treatment success. Long-term data on adherence to biologic treatment in psoriasis are lacking.To compare the tumour necrosis factor (TNF)-α inhibitors regarding drug survival rate and safety in patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bcde46cbf9df362cb2ac087b128acadf
https://pubmed.ncbi.nlm.nih.gov/21801162
Zobrazit plný text záznamu
9
Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy
Autor: C, Johansen, H, Vinter, L, Soegaard-Madsen, L R, Olsen, T, Steiniche, L, Iversen, K, Kragballe
Publikováno v: The British journal of dermatology. 163(6)
Anti-TNFα therapies are well established for severe psoriasis; however, their mechanism of action in disease resolution is not fully understood. p38 mitogen-activated protein kinase (MAPK) is a kinase known to play a key role in the pathogenesis of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::646166cde116ce9b0c3d4f3c657e4da5
https://pubmed.ncbi.nlm.nih.gov/20846304
Zobrazit plný text záznamu
10
Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement
Autor: L, Soegaard-Madsen, C, Johansen, L, Iversen, K, Kragballe
Publikováno v: The British journal of dermatology. 162(6)
The pathogenesis of psoriasis and the mechanisms of action of antitumour necrosis factor (TNF)-α therapies are incompletely understood.To investigate the early molecular effects of adalimumab in psoriatic skin.Biopsies taken from patients with psori
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dee30e845c4a11cbac80e951c24775fe
https://pubmed.ncbi.nlm.nih.gov/20346019
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje